Hamborner REIT Valuation
Is 0MCG undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 0MCG when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 0MCG (€6.34) is trading below our estimate of fair value (€8.43)
Significantly Below Fair Value: 0MCG is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 0MCG?
Key metric: As 0MCG is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is 0MCG's PE Ratio? | |
|---|---|
| PE Ratio | 63.7x |
| Earnings | €8.19m |
| Market Cap | €521.41m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 11.2x |
| Enterprise Value/EBITDA | 17.9x |
| PEG Ratio | 5.8x |
Price to Earnings Ratio vs Peers
How does 0MCG's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 60.2x | ||
NRR NewRiver REIT | 96.8x | 33.0% | UK£290.5m |
CAL Capital & Regional | 68.7x | 47.8% | UK£144.2m |
SHC Shaftesbury Capital | 65.6x | 28.4% | UK£2.5b |
WHR Warehouse REIT | 9.8x | 8.7% | UK£367.5m |
0MCG Hamborner REIT | 63.7x | 11.0% | €521.4m |
Price-To-Earnings vs Peers: 0MCG is expensive based on its Price-To-Earnings Ratio (63.7x) compared to the peer average (60.2x).
Price to Earnings Ratio vs Industry
How does 0MCG's PE Ratio compare vs other companies in the European Retail REITs Industry?
| 0 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 0 Companies | Estimated Growth | Market Cap |
|---|
Price-To-Earnings vs Industry: 0MCG is expensive based on its Price-To-Earnings Ratio (63.7x) compared to the European Retail REITs industry average (22.5x).
Price to Earnings Ratio vs Fair Ratio
What is 0MCG's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 63.7x |
| Fair PE Ratio | 15.8x |
Price-To-Earnings vs Fair Ratio: 0MCG is expensive based on its Price-To-Earnings Ratio (63.7x) compared to the estimated Fair Price-To-Earnings Ratio (15.8x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €6.34 | €8.05 +27.0% | 7.1% | €9.00 | €7.20 | n/a | 5 |
| Nov ’25 | €6.54 | €8.05 +23.1% | 7.1% | €9.00 | €7.20 | n/a | 5 |
| Oct ’25 | €6.64 | €8.05 +21.2% | 7.1% | €9.00 | €7.20 | n/a | 5 |
| Sep ’25 | €6.55 | €8.05 +22.9% | 7.1% | €9.00 | €7.20 | n/a | 5 |
| Aug ’25 | €6.54 | €8.05 +23.1% | 7.1% | €9.00 | €7.20 | n/a | 5 |
| Jul ’25 | €6.55 | €8.05 +22.9% | 7.1% | €9.00 | €7.20 | n/a | 5 |
| Jun ’25 | €6.63 | €8.05 +21.4% | 7.1% | €9.00 | €7.20 | n/a | 5 |
| May ’25 | €6.40 | €8.05 +25.8% | 7.9% | €9.00 | €7.20 | n/a | 4 |
| Apr ’25 | €6.86 | €8.07 +17.5% | 9.1% | €9.00 | €7.20 | n/a | 3 |
| Mar ’25 | €6.31 | €8.33 +32.1% | 5.7% | €9.00 | €8.00 | n/a | 3 |
| Feb ’25 | €6.41 | €8.63 +34.7% | 5.2% | €9.00 | €8.00 | n/a | 3 |
| Jan ’25 | €6.80 | €8.83 +29.9% | 7.1% | €9.50 | €8.00 | n/a | 3 |
| Dec ’24 | €6.58 | €8.83 +34.2% | 7.1% | €9.50 | €8.00 | n/a | 3 |
| Nov ’24 | €6.26 | €8.83 +41.1% | 7.1% | €9.50 | €8.00 | €6.54 | 3 |
| Oct ’24 | €6.45 | €8.83 +37.0% | 7.1% | €9.50 | €8.00 | €6.64 | 3 |
| Sep ’24 | €6.57 | €8.83 +34.4% | 7.1% | €9.50 | €8.00 | €6.55 | 3 |
| Aug ’24 | €6.53 | €8.63 +32.1% | 7.5% | €9.50 | €8.00 | €6.54 | 4 |
| Jul ’24 | €6.46 | €8.83 +36.7% | 7.1% | €9.50 | €8.00 | €6.55 | 3 |
| Jun ’24 | €6.65 | €9.33 +40.4% | 10.1% | €10.00 | €8.00 | €6.63 | 3 |
| May ’24 | €7.14 | €9.33 +30.7% | 10.1% | €10.00 | €8.00 | €6.40 | 3 |
| Apr ’24 | €7.27 | €9.33 +28.4% | 10.1% | €10.00 | €8.00 | €6.86 | 3 |
| Mar ’24 | €7.52 | €9.33 +24.1% | 10.1% | €10.00 | €8.00 | €6.31 | 3 |
| Feb ’24 | €7.24 | €10.00 +38.1% | 16.3% | €12.00 | €8.00 | €6.41 | 3 |
| Jan ’24 | €6.79 | €10.00 +47.3% | 16.3% | €12.00 | €8.00 | €6.80 | 3 |
| Dec ’23 | €7.31 | €11.10 +51.8% | 7.5% | €12.00 | €10.00 | €6.58 | 3 |
| Nov ’23 | €7.35 | €11.47 +56.0% | 3.4% | €12.00 | €11.10 | €6.26 | 3 |
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.
Discover undervalued companies
Big Yellow Group
UK£2.2b
Big Yellow is the UK's brand leader in self storage.
BYG
UK£11.04
7D
-4.3%
1Y
0.9%
Immobiliare Grande Distribuzione SIIQ
€251.6m
Immobiliare Grande Distribuzione SIIQ S.p.A.
0STP
€2.25
7D
3.8%
1Y
2.7%
Care REIT
UK£359.3m
Impact Healthcare REIT plc acquires, renovates, extends and redevelops high quality healthcare real estate assets in the UK and lets these assets on long-term full repairing and insuring leases to high-quality established healthcare operators which offer good quality care, under leases which provide the Company with attractive levels of rent cover.
CRT
UK£0.87
7D
5.7%
1Y
1.0%